Companies / Legend Bio
Legend Bio
USA
The company develops cutting-edge cell therapies for diseases considered intractable and incurable
Legend Bio, based in USA, has 2 investors on file, among them Lilly Asia Ventures and RA Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Lilly Asia Ventures
60 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (96%), Fintech (2%), Robotics & Hardware (2%).
See Lilly Asia Ventures' full profile · Who invests alongside it
More from RA Capital
215 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (86%), Industrial & Manufacturing (4%), AI & Machine Learning (2%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Legend Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lilly Asia Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/legendbiotech.com/investors
# also
GET /v1/companies/legendbiotech.com
GET /v1/companies/legendbiotech.com/news